Skip to main content
Erschienen in:

25.02.2021 | Clinical Investigation

Efficacy of compartmentalization in controlling an adenovirus type 54 keratoconjunctivitis outbreak on Oki Island, Japan

verfasst von: Yutaka Omatsu, Dai Miyazaki, Yumiko Shimizu, Kazuki Matsuura, Shin-ichi Sasaki, Yoshitsugu Inoue, Eiichi Uchio, Tsuguto Fujimoto

Erschienen in: Japanese Journal of Ophthalmology | Ausgabe 3/2021

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To analyze the epidemiologic characteristics of an outbreak of human adenovirus type 54 (HAdV-54) on Oki Island, Shimane Prefecture, Japan, in 2017 and to assess the effectiveness of a compartmentalization method in controlling the incidence and spread.

Study design

Retrospective cohort study.

Methods

The infection was diagnosed in 136 individuals, and typing was confirmed by PCR and direct sequencing. The epidemiologic characteristics of the disease including the infection rate, incubation period, and basic reproductive number (R0), ie, number of cases directly infected by an infectious patient during the course of the disease, were investigated. The effectiveness of compartmentalization for infection control was determined by simulating the outbreak using the Susceptible-Exposed-Infectious-Recovered (SEIR) model.

Results

The majority of the HAdV-54-infected individuals were the children of 3 nursery schools (A, B, and C) and their parents on Oki Island. The infection rates in the 3 schools were 13.2%, 16.9%, and 17.2%, respectively. The one class of school B without the index case was initially compartmentalized, and the infection rate in this compartment was 0%. The incubation period was calculated to be 9.3 ± 3.5 days, and the disease duration, 13.0 ± 5.4 days. The R0 was 1.43. Using these parameters, a SEIR model was constructed. The SEIR model well predicted the daily incidence of infection and indicated that the compartmentalization method provides effective reduction in the incidence of the infection, with much earlier control.

Conclusions

The compartmentalization method is effective to control HAdV-54 outbreaks.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Darougar S, Grey RH, Thaker U, McSwiggan DA. Clinical and epidemiological features of adenovirus keratoconjunctivitis in London. Br J Ophthalmol. 1983;67:1–7.CrossRef Darougar S, Grey RH, Thaker U, McSwiggan DA. Clinical and epidemiological features of adenovirus keratoconjunctivitis in London. Br J Ophthalmol. 1983;67:1–7.CrossRef
2.
Zurück zum Zitat Hara J, Okamoto S, Minekawa Y, Yamazaki K, Kase T. Survival and disinfection of adenovirus type 19 and enterovirus 70 in ophthalmic practice. Jpn J Ophthalmol. 1990;34:421–7.PubMed Hara J, Okamoto S, Minekawa Y, Yamazaki K, Kase T. Survival and disinfection of adenovirus type 19 and enterovirus 70 in ophthalmic practice. Jpn J Ophthalmol. 1990;34:421–7.PubMed
3.
Zurück zum Zitat Chintakuntlawar AV, Zhou X, Rajaiya J, Chodosh J. Viral capsid is a pathogen-associated molecular pattern in adenovirus keratitis. PLoS Pathog. 2010;6:e1000841.CrossRef Chintakuntlawar AV, Zhou X, Rajaiya J, Chodosh J. Viral capsid is a pathogen-associated molecular pattern in adenovirus keratitis. PLoS Pathog. 2010;6:e1000841.CrossRef
4.
Zurück zum Zitat Aydin Kurna S, Altun A, Oflaz A, Karatay AA. Evaluation of the impact of persistent subepithelial corneal infiltrations on the visual performance and corneal optical quality after epidemic keratoconjunctivitis. Acta Ophthalmol. 2015;93:377–82.CrossRef Aydin Kurna S, Altun A, Oflaz A, Karatay AA. Evaluation of the impact of persistent subepithelial corneal infiltrations on the visual performance and corneal optical quality after epidemic keratoconjunctivitis. Acta Ophthalmol. 2015;93:377–82.CrossRef
5.
Zurück zum Zitat Lee CS, Lee AY, Akileswaran L, Stroman D, Najafi-Tagol K, Kleiboeker S, et al. Determinants of outcomes of adenoviral keratoconjunctivitis. Ophthalmology. 2018;125:1344–53.CrossRef Lee CS, Lee AY, Akileswaran L, Stroman D, Najafi-Tagol K, Kleiboeker S, et al. Determinants of outcomes of adenoviral keratoconjunctivitis. Ophthalmology. 2018;125:1344–53.CrossRef
6.
Zurück zum Zitat Gonzalez G, Yawata N, Aoki K, Kitaichi N. Challenges in management of epidemic keratoconjunctivitis with emerging recombinant human adenoviruses. J Clin Virol. 2019;112:1–9.CrossRef Gonzalez G, Yawata N, Aoki K, Kitaichi N. Challenges in management of epidemic keratoconjunctivitis with emerging recombinant human adenoviruses. J Clin Virol. 2019;112:1–9.CrossRef
7.
Zurück zum Zitat Akiyoshi K, Suga T, Fukui K, Taniguchi K, Okabe N, Fujimoto T. Outbreak of epidemic keratoconjunctivitis caused by adenovirus type 54 in a nursery school in Kobe City, Japan in 2008. Jpn J Infect Dis. 2011;64:353–5.PubMed Akiyoshi K, Suga T, Fukui K, Taniguchi K, Okabe N, Fujimoto T. Outbreak of epidemic keratoconjunctivitis caused by adenovirus type 54 in a nursery school in Kobe City, Japan in 2008. Jpn J Infect Dis. 2011;64:353–5.PubMed
8.
Zurück zum Zitat Nakamura M, Hirano E, Kowada K, Ishiguro F, Yamagishi Z, Adhikary AK, et al. Surveillance of adenovirus D in patients with epidemic keratoconjunctivitis from Fukui Prefecture, Japan, 1995–2010. J Med Virol. 2012;84:81–6.CrossRef Nakamura M, Hirano E, Kowada K, Ishiguro F, Yamagishi Z, Adhikary AK, et al. Surveillance of adenovirus D in patients with epidemic keratoconjunctivitis from Fukui Prefecture, Japan, 1995–2010. J Med Virol. 2012;84:81–6.CrossRef
9.
Zurück zum Zitat Uemura T, Migita H, Ueno T, Tsukahara-Kawamura T, Saeki Y, Fujimoto T, et al. Clinical and virological analysis of epidemic keratoconjunctivitis caused by adenovirus type 54 in a regional ophthalmic clinic in Kyushu. Japan Clin Ophthalmol. 2018;12:511–7.CrossRef Uemura T, Migita H, Ueno T, Tsukahara-Kawamura T, Saeki Y, Fujimoto T, et al. Clinical and virological analysis of epidemic keratoconjunctivitis caused by adenovirus type 54 in a regional ophthalmic clinic in Kyushu. Japan Clin Ophthalmol. 2018;12:511–7.CrossRef
10.
Zurück zum Zitat 10Hirai Y, Kaita A, Yamamoto S, Kubo H, Iritani N, Ogasawara J. Detection of adenovirus type 54 in patients with epidemic keratoconjunctivitis, 2016-Osaka. Article in Japanese. Infect Agents Surveill Rep. 2018;39:2. 10Hirai Y, Kaita A, Yamamoto S, Kubo H, Iritani N, Ogasawara J. Detection of adenovirus type 54 in patients with epidemic keratoconjunctivitis, 2016-Osaka. Article in Japanese. Infect Agents Surveill Rep. 2018;39:2.
11.
Zurück zum Zitat 11Anderson RM, May RM. Infectious diseases of humans: dynamics and control. Oxford University Press; 1991. 11Anderson RM, May RM. Infectious diseases of humans: dynamics and control. Oxford University Press; 1991.
12.
Zurück zum Zitat 12Fujimoto T, Hanaoka N, Shimizu H, Matsushima Y, Okabe N, Hagi M, et al. Diagnostic manual for pharyngeal conjunctival fever and epidemic keratoconjunctivitis. 2nd ed. National Institute of Infectious Diseases; 2012. 12Fujimoto T, Hanaoka N, Shimizu H, Matsushima Y, Okabe N, Hagi M, et al. Diagnostic manual for pharyngeal conjunctival fever and epidemic keratoconjunctivitis. 2nd ed. National Institute of Infectious Diseases; 2012.
13.
Zurück zum Zitat Takeuchi S, Itoh N, Uchio E, Aoki K, Ohno S. Serotyping of adenoviruses on conjunctival scrapings by PCR and sequence analysis. J Clin Microbiol. 1999;37:1839–45.CrossRef Takeuchi S, Itoh N, Uchio E, Aoki K, Ohno S. Serotyping of adenoviruses on conjunctival scrapings by PCR and sequence analysis. J Clin Microbiol. 1999;37:1839–45.CrossRef
14.
Zurück zum Zitat Xu W, McDonough MC, Erdman DD. Species-specific identification of human adenoviruses by a multiplex PCR assay. J Clin Microbiol. 2000;38:4114–20.CrossRef Xu W, McDonough MC, Erdman DD. Species-specific identification of human adenoviruses by a multiplex PCR assay. J Clin Microbiol. 2000;38:4114–20.CrossRef
15.
Zurück zum Zitat Fujimoto T, Matsushima Y, Shimizu H, Ishimaru Y, Kano A, Nakajima E, et al. A molecular epidemiologic study of human adenovirus type 8 isolates causing epidemic keratoconjunctivitis in Kawasaki City, Japan in 2011. Jpn J Infect Dis. 2012;65:260–3.CrossRef Fujimoto T, Matsushima Y, Shimizu H, Ishimaru Y, Kano A, Nakajima E, et al. A molecular epidemiologic study of human adenovirus type 8 isolates causing epidemic keratoconjunctivitis in Kawasaki City, Japan in 2011. Jpn J Infect Dis. 2012;65:260–3.CrossRef
16.
Zurück zum Zitat Khan A, Naveed M, Dur EAM, Imran M. Estimating the basic reproductive ratio for the Ebola outbreak in Liberia and Sierra Leone. Infect Dis Poverty. 2015;4:13.CrossRef Khan A, Naveed M, Dur EAM, Imran M. Estimating the basic reproductive ratio for the Ebola outbreak in Liberia and Sierra Leone. Infect Dis Poverty. 2015;4:13.CrossRef
17.
Zurück zum Zitat Gaythorpe KAM, Trotter CL, Lopman B, Steele M, Conlan AJK. Norovirus transmission dynamics: a modelling review. Epidemiol Infect. 2018;146:147–58.CrossRef Gaythorpe KAM, Trotter CL, Lopman B, Steele M, Conlan AJK. Norovirus transmission dynamics: a modelling review. Epidemiol Infect. 2018;146:147–58.CrossRef
18.
Zurück zum Zitat Liu Y, Gayle AA, Wilder-Smith A, Rocklöv J. (2020) The reproductive number of COVID-19 is higher compared to SARS coronavirus. J Travel Med. 27:taaa021. Liu Y, Gayle AA, Wilder-Smith A, Rocklöv J. (2020) The reproductive number of COVID-19 is higher compared to SARS coronavirus. J Travel Med. 27:taaa021.
19.
Zurück zum Zitat Shoman H, Karafillakis E, Rawaf S. The link between the West African Ebola outbreak and health systems in Guinea, Liberia and Sierra Leone: a systematic review. Global Health. 2017;13:1.CrossRef Shoman H, Karafillakis E, Rawaf S. The link between the West African Ebola outbreak and health systems in Guinea, Liberia and Sierra Leone: a systematic review. Global Health. 2017;13:1.CrossRef
20.
Zurück zum Zitat Glass RI, Parashar UD, Estes MK. Norovirus gastroenteritis. N Engl J Med. 2009;361:1776–85.CrossRef Glass RI, Parashar UD, Estes MK. Norovirus gastroenteritis. N Engl J Med. 2009;361:1776–85.CrossRef
21.
Zurück zum Zitat Estes MK, Prasad BVV, Atmar RL. Noroviruses everywhere: Has something changed? Curr Opin Infect Dis. 2006;19:467–74.CrossRef Estes MK, Prasad BVV, Atmar RL. Noroviruses everywhere: Has something changed? Curr Opin Infect Dis. 2006;19:467–74.CrossRef
22.
Zurück zum Zitat Haill CF, Newell P, Ford C, Whitley M, Cox J, Wallis M, et al. Compartmentalization of wards to cohort symptomatic patients at the beginning and end of norovirus outbreaks. J Hosp Infect. 2012;82:30–5.CrossRef Haill CF, Newell P, Ford C, Whitley M, Cox J, Wallis M, et al. Compartmentalization of wards to cohort symptomatic patients at the beginning and end of norovirus outbreaks. J Hosp Infect. 2012;82:30–5.CrossRef
23.
Zurück zum Zitat Wiersinga WJ, Rhodes A, Cheng AC, Peacock SJ, Prescott HC. Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19): a review. JAMA. 2020;324:782–93.CrossRef Wiersinga WJ, Rhodes A, Cheng AC, Peacock SJ, Prescott HC. Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19): a review. JAMA. 2020;324:782–93.CrossRef
25.
Zurück zum Zitat Byambasuren O, Cardona M, Bell K, Clark J, McLaws M-L, Glasziou P. Estimating the extent of asymptomatic COVID-19 and its potential for community transmission: systematic review and meta-analysis. medRxiv. 2020. doi:10.1101.2020.05.10.20097543 Byambasuren O, Cardona M, Bell K, Clark J, McLaws M-L, Glasziou P. Estimating the extent of asymptomatic COVID-19 and its potential for community transmission: systematic review and meta-analysis. medRxiv. 2020. doi:10.1101.2020.05.10.20097543
Metadaten
Titel
Efficacy of compartmentalization in controlling an adenovirus type 54 keratoconjunctivitis outbreak on Oki Island, Japan
verfasst von
Yutaka Omatsu
Dai Miyazaki
Yumiko Shimizu
Kazuki Matsuura
Shin-ichi Sasaki
Yoshitsugu Inoue
Eiichi Uchio
Tsuguto Fujimoto
Publikationsdatum
25.02.2021
Verlag
Springer Japan
Erschienen in
Japanese Journal of Ophthalmology / Ausgabe 3/2021
Print ISSN: 0021-5155
Elektronische ISSN: 1613-2246
DOI
https://doi.org/10.1007/s10384-021-00826-8

Neu im Fachgebiet Augenheilkunde

Kompetente Gesprächsführung

Mit schwierigen Gesprächen und der Übermittlung schlechter Nachrichten ist der Augenarzt/die Augenärztin im Krankenhaus und in der Praxis immer wieder konfrontiert. Eine gute Arzt-Patienten-Kommunikation basiert auf Respekt und Empathie und …

Sekundäre chorioidale Neovaskularisation – Wirklich so häufig?

Das Auftreten einer sekundären chorioidalen Neovaskularisation ist eine Komplikation im Rahmen einer chronischen Chorioretinopathia centralis serosa. Die Diagnose wird mittels multimodaler Bildgebung gestellt. Die Therapie erfolgt in der Regel mit …

Therapie der Chorioretinopathia centralis serosa im Vergleich – Mikrosekundenpulslaser versus photodynamische Therapie

Zum gegenwärtigen Zeitpunkt steht für die Behandlung der Chorioretinopathia centralis serosa (CCS) keine zugelassene Therapie zur Verfügung. Obwohl die CCS eine hohe Selbstresorptionsrate aufweist, können häufige Rezidive oder eine Chronifizierung …

Diagnostik und Klassifikation der Chorioretinopathia centralis serosa – Was brauche ich wirklich?

Die multimodale Bildgebung spielt bei der Diagnostik und Klassifikation der Chorioretinopathia centralis serosa (CCS) eine bedeutende Rolle. In diesem Beitrag sollen die wichtigsten Bildgebungsmodalitäten bei der CCS wie optische …

Update Augenheilkunde

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.